Vizex Investments Ltd
financial consultations

Last news

Long term recommendation - Immune Pharmaceuticals (NASDAQ.IMNP)

Feb 04, 2018 35
Febryary 4th. We are starting coverage…

Transenterix completely sold the rights on the Surgibot

Dec 18, 2017 36
December 18th 2017. Transenterix…

We no longer recommend Array Biopharma Inc

November 11th 2017.  We are withdrawing our recommendation on Array Biopharma.  Please see or ARTICLES section for financial results of the recommendation.  Congratulations to all the long term investors who have been following the stock over 1 year period.  We are looking forward to publishing a new long term free recommendation in the coming days.  Keep checking our site.

Вайзекс Инвестментс ООД © 2015 | Всички права запазени